Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivitrol in opioid addicted prisoners before vs after reentry
NCT02617628Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- Jan 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in opioid use disorder (OUD), sponsored by University of Pennsylvania. Started Jan 2016; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02617628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02617628.